ciprofloxacin has been researched along with mitomycin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 8 (29.63) | 29.6817 |
| 2010's | 15 (55.56) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Hooper, DC; Jacoby, GA; Mills, DM; Wang, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Fu, XM; Guo, ZY; Lin, YC; Shao, CL; She, ZG; Wang, CY; Wei, MY; Xu, RF; Yang, KL; Zheng, CJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Hamid, A; Jaglan, S; Klapötke, TM; Kumar, D; Narasimhan, B; Qazi, AK; Singh, K; Stierstorfer, J; Verma, V | 1 |
| Aly, AH; Bara, R; Brötz-Oesterhelt, H; Debbab, A; Goldbach-Gecke, H; Kurtán, T; Lin, W; Mándi, A; Polavarapu, PL; Pretsch, A; Proksch, P; Raghavan, V; Sass, P; Wray, V; Zerfass, I | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arumugam, P; Balasubramanian, S; Chavali, M; Jayaraman, VB; Kumar, CG; Muthusamy, K; Poornachandra, Y; Sriram, KK; Swapnaja, KJ; Yennam, S | 1 |
| Aleman Lopez, PA; Anton-Fos, GM; Bueso-Bordils, JI; Duart, MJ; Lahuerta Zamora, L; Martin Algarra, RV; Perez-Gracia, MT; Suay-Garcia, B | 1 |
| Clarke, RS; Cook, DT; Edwards, AM; Evans, LE; Gavin, LA; Ha, KP; Hutton, JA; Lanyon-Hogg, T; Lim, CSQ; Sutherell, CL; Tate, EW | 1 |
| Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
| Fay, M; Gougerot-Pocidalo, MA; Roche, Y | 1 |
| Buchrieser, C; Kaspar, CW | 1 |
| Chatterji, M; Nagaraja, V; Sengupta, S | 1 |
| Beaber, JW; Hochhut, B; Waldor, MK | 1 |
| Burgués, JP; Gómez, L; Jiménez-Cruz, JF; Ozonas, M; Pontones, JL; Vera, CD | 1 |
| Jofre, J; Muniesa, M | 1 |
| Jalava, J; Kuipers, OP; Savijoki, K; Varhimo, E; Varmanen, P | 1 |
| Chen, Z; Lee, CY; Luong, TT | 1 |
| Davies, J; Mesak, LR | 1 |
| Gavin, M; Hooper, DC; Jacoby, GA; Liao, CH; Okumura, R | 1 |
| Fortier, LC; Meessen-Pinard, M; Sekulovic, O | 1 |
| Bavari, S; Bowlin, TL; Deshazer, D; Kenny, TA; Moir, DT; Moravusova, A; Opperman, T; Panchal, RG; Ulrich, MP; Ulrich, RL | 1 |
| Ardanuy, C; de la Campa, AG; Domenech, A; Ferrándiz, MJ; Frias, MJ; García, E; Liñares, J; López, E; Ramirez, M | 1 |
| Chowdhury, N; Kwan, BW; Wood, TK | 1 |
| Abu-Raddad, LJ; Al Khal, A; Al Romaihi, HE; Al-Maslamani, M; Al-Thani, MH; Chemaitelly, H; Elmagboul, EBI; Puthiyottil, A; Unemo, M; Varghese, MK | 1 |
1 review(s) available for ciprofloxacin and mitomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
26 other study(ies) available for ciprofloxacin and mitomycin
| Article | Year |
|---|---|
SOS regulation of qnrB expression.
Topics: Alleles; Base Sequence; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Expression; Mitomycin; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Plasmids; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; SOS Response, Genetics | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
Topics: Animals; Anthraquinones; Anti-Bacterial Agents; Ascomycota; Bacillus subtilis; Ciprofloxacin; Crystallography, X-Ray; Escherichia coli; Marine Biology; Microbial Sensitivity Tests; Micrococcus luteus; Molecular Structure; Sea Anemones; Staphylococcus aureus | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis, antimicrobial and cytotoxicity study of 1,3-disubstituted-1H-naphtho[1,2-e][1,3]oxazines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Candida albicans; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Atropisomeric dihydroanthracenones as inhibitors of multiresistant Staphylococcus aureus.
Topics: Aloe; Animals; Anthracenes; Anti-Bacterial Agents; BALB 3T3 Cells; Cell Line, Tumor; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endophytes; Eurotiales; Humans; Mice; Microbial Sensitivity Tests; Nuclear Magnetic Resonance, Biomolecular; SOS Response, Genetics; Staphylococcus aureus; Stereoisomerism | 2013 |
Design, synthesis and biological evaluation of diaziridinyl quinone isoxazole hybrids.
Topics: A549 Cells; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Biofilms; Cell Line, Tumor; Cytotoxins; Humans; Isoxazoles; Microbial Sensitivity Tests; Quinones | 2016 |
Topological pattern for the search of new active drugs against methicillin resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship | 2017 |
Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; DNA Repair; DNA, Bacterial; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Small Molecule Libraries; Structure-Activity Relationship | 2019 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Mitomycin; Mitomycins; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Receptors, Immunologic; Receptors, Interleukin-2 | 1988 |
An improved direct viable count for the enumeration of bacteria in milk.
Topics: Animals; Bacteria; Cell Division; Ciprofloxacin; Colony Count, Microbial; Food Microbiology; Milk; Mitomycin; Nalidixic Acid; Novobiocin | 1993 |
Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
Topics: Alkylating Agents; beta-Galactosidase; Ciprofloxacin; DNA Damage; DNA, Bacterial; DNA, Superhelical; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Genes, Reporter; Methylnitronitrosoguanidine; Mitomycin; Mutagenesis; Nalidixic Acid; Plasmids; Quinolones; Repressor Proteins; SOS Response, Genetics; Topoisomerase II Inhibitors; Ultraviolet Rays | 2003 |
SOS response promotes horizontal dissemination of antibiotic resistance genes.
Topics: Bacterial Proteins; Chloramphenicol Resistance; Ciprofloxacin; Conjugation, Genetic; DNA Damage; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Mitomycin; Models, Genetic; Rec A Recombinases; Repressor Proteins; SOS Response, Genetics; Vibrio cholerae | 2004 |
A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Topics: Antineoplastic Agents; Ciprofloxacin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Spheroids, Cellular; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil | 2007 |
The contribution of induction of temperate phages to the numbers of free somatic coliphages in waters is not significant.
Topics: Ciprofloxacin; Coliphages; Mitomycin; Ultraviolet Rays; Virus Activation; Water Microbiology | 2007 |
Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Blotting, Northern; Ciprofloxacin; DNA Damage; Drug Resistance, Bacterial; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Bacterial; Genes, Bacterial; Mitomycin; Models, Genetic; Molecular Sequence Data; Mutagenesis; Mutation; Operon; Rifampin; Sequence Homology, Nucleic Acid; SOS Response, Genetics; Streptococcus; Ultraviolet Rays | 2007 |
The sbcDC locus mediates repression of type 5 capsule production as part of the SOS response in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Artificial Gene Fusion; Bacterial Capsules; Bacterial Proteins; beta-Galactosidase; Blotting, Northern; Blotting, Western; Ciprofloxacin; Deoxyribonucleases; Exonucleases; Gene Deletion; Gene Expression Regulation, Bacterial; Genes, Reporter; Microbial Viability; Mitomycin; Promoter Regions, Genetic; Repressor Proteins; RNA, Bacterial; RNA, Messenger; SOS Response, Genetics; Staphylococcus aureus; Transcription, Genetic; Ultraviolet Rays | 2007 |
Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.
Topics: Antibiotics, Antineoplastic; Aza Compounds; Bacterial Proteins; Ciprofloxacin; DNA Mismatch Repair; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Gene Expression Regulation, Bacterial; Mitomycin; Moxifloxacin; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenotype; Quinolines; SOS Response, Genetics; Staphylococcus aureus | 2009 |
Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mitomycin; Plasmids; Quinolones; SOS Response, Genetics; Vibrio | 2011 |
Evidence of in vivo prophage induction during Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA, Viral; Feces; Fluoroquinolones; Genetic Variation; Genome, Viral; Humans; Levofloxacin; Lysogeny; Microbial Sensitivity Tests; Mitomycin; Molecular Sequence Data; Moxifloxacin; Myoviridae; Ofloxacin; Prophages; Quinolines; Sequence Analysis, DNA; Virus Activation | 2012 |
Characterization of the Burkholderia thailandensis SOS response by using whole-transcriptome shotgun sequencing.
Topics: Anti-Bacterial Agents; Bacteriophages; Burkholderia; Ciprofloxacin; Mitomycin; Mutagens; Protein Biosynthesis; Sequence Analysis, DNA; Siphoviridae; SOS Response, Genetics; Transcription, Genetic; Transcriptome | 2013 |
Induction of prophages by fluoroquinolones in Streptococcus pneumoniae: implications for emergence of resistance in genetically-related clones.
Topics: Blotting, Southern; Chronic Disease; Ciprofloxacin; Disease Progression; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Lysogeny; Mitomycin; Pneumococcal Infections; Polymerase Chain Reaction; Prophages; Streptococcus pneumoniae; Virus Activation | 2014 |
Combatting bacterial infections by killing persister cells with mitomycin C.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ciprofloxacin; Cross-Linking Reagents; Cystic Fibrosis; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli K12; Humans; Mitomycin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2015 |
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Mitomycin; Neisseria gonorrhoeae; Qatar; Tetracycline | 2022 |